Moffitt is piloting EMMA, an AI-driven lab platform that screens myeloma cells against 31 drugs to speed personalized treatment decisions.

Visa has embedded its payments network into ChatGPT, letting AI agents buy for users while banks and merchants raise fraud and fee questions. The shift moves agentic shopping from experiments toward network rails.

Federal prosecutors say LangInnov settled after allegedly performing SBIR‑funded R&D overseas, a possible breach of NSF rules. The U.S. Attorney’s office framed the move as enforcement of domestic R&D requirements.

UCHealth surgeons in Aurora have started offering the FDA‑approved TOUCH CMC 1 thumb implant, a European ball‑joint replacement that promises less pain and a quicker recovery. About 50 patients are already lined up.

San Diego’s Autobahn secured FDA Fast Track for elunetirom and reported strong Phase 2 topline results in a small bipolar depression study. The findings are promising but preliminary.

GM is partnering with Peak Energy to co‑develop sodium‑ion batteries for grid storage — a move aimed at easing electricity demand from AI data centers and kick‑starting domestic production. Trial samples are expected in 2028.

A Northwestern professor and four other diabetes researchers were escorted from the ADA Scientific Sessions in New Orleans after distributing reprints of a Diabetes Care editorial critical of proposed NIH policy changes.

UH Hilo is a core partner in NOAA’s new CIFARM initiative, which brings a $13.5M initial investment to expand sustainable aquaculture and pilot farms in Hilo.

Red Hat and IBM launched Project Lightwell, a $5B initiative pairing AI and thousands of engineers to hunt and patch open-source vulnerabilities. The effort spotlights Raleigh's tech role.

Edward Hines Jr. VA Hospital in suburban Chicago has begun enrolling veterans in a supervised psilocybin-assisted therapy trial for treatment‑resistant PTSD.

Brussels ordered Meta to reopen WhatsApp to rival AI assistants under interim measures while it probes whether the company locked competitors out. The move raises big compliance and business questions for developers.

The Yawkey Foundation pledged $50M to Dana‑Farber to support construction of a new inpatient cancer hospital and related patient care programs in Boston.

Long Island scientists are growing patient 'avatars' — organoids — to test dozens of drug combinations. Early trials show promise but wider validation and faster methods are still needed.